EUVIMEDEUVIMED entdecken
Open Access · CC0

Diagnostic performance of the GenoType MTBDRplus VER 2.0 line probe assay for the detection of isoniazid resistant Mycobacterium tuberculosis in Ethiopia

Shewki Moga iD, Kidist Bobosha, Dinka Fikadu, Betselot Zerihun iD, Getu Diriba iD, Misikir Amare, Russell R Kempker, Henry M Blumberg, Tamrat Abebe

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0284737 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Shewki Moga und 8 weiteren Autor:innen. Beteiligte Einrichtung: Ethiopian Public Health Institute (EPHI), Addis Ababa, Ethiopia. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis, Multidrug-Resistant. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: FIC NIH HHS, NIAID NIH HHS, Fogarty International Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Isoniazid (INH) resistant Mycobacterium tuberculosis (Hr-TB) is the most common type of drug resistant TB, and is defined as M tuberculosis complex (MTBC) strains resistant to INH but susceptible to rifampicin (RIF). Resistance to INH precedes RIF resistance in almost all multidrug resistant TB (MDR-TB) cases, across all MTBC lineages and in all settings. Therefore, early detection of Hr-TB is critical to ensure rapid initiation of appropriate treatment, and to prevent progression to MDR-TB. We assessed the performance of the GenoType MTBDR plus VER 2.0 line probe assay (LPA) in detecting isoniazid resistance among MTBC clinical isolates.

Methods

A retrospective study was conducted among M . tuberculosis complex (MTBC) clinical isolates obtained from the third-round Ethiopian national drug resistance survey (DRS) conducted between August 2017 and December 2019. The sensitivity, specificity, positive predictive value, and negative predictive value of the GenoType MTBDR plus VER 2.0 LPA in detecting INH resistance were assessed and compared to phenotypic drug susceptibility testing (DST) using the Mycobacteria Growth Indicator Tube (MGIT) system. Fisher’s exact test was performed to compare the performance of LPA between Hr-TB and MDR-TB isolates.

Results

A total of 137 MTBC isolates were included, of those 62 were Hr-TB, 35 were MDR-TB and 40 were INH susceptible. The sensitivity of the GenoType MTBDR plus VER 2.0 for detecting INH resistance was 77.4% (95% CI: 65.5–86.2) among Hr-TB isolates and 94.3% (95% CI: 80.4–99.4) among MDR-TB isolates ( P = 0.04). The specificity of the GenoType MTBDR plus VER 2.0 for detecting INH resistance was 100% (95% CI: 89.6–100). The katG 315 mutation was observed in 71% (n = 44) of Hr-TB phenotypes and 94.3% (n = 33) of MDR-TB phenotypes. Mutation at position-15 of the inh A promoter region alone was detected in four (6.5%) Hr-TB isolates, and concomitantly with katG 315 mutation in one (2.9%) MDR-TB isolate.

Conclusions

GenoType MTBDR plus VER 2.0 LPA demonstrated improved performance in detecting INH resistance among MDR-TB cases compared to Hr-TB cases. The kat G315 mutation is the most common INH resistance conferring gene among Hr-TB and MDR-TB isolates. Additional INH resistance conferring mutations should be evaluated to improve the sensitivity of the GenoType MTBDR plus VER 2.0 for the detection of INH resistance among Hr-TB cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisTuberculosis, Multidrug-ResistantHumansIsoniazidAntitubercular AgentsEthiopiaMicrobial Sensitivity TestsRetrospective StudiesRifampinGenotypeMutation

Substanzen

IsoniazidAntitubercular AgentsRifampin

Autor:innen und Institutionen

  • Ethiopian Public Health Institute (EPHI), Addis Ababa, Ethiopia.
  • Department of Microbiology, Immunology, and Parasitology, School of Medicine, College of Health Sciences, Addis Ababa University (AAU), Addis Ababa, Ethiopia.
  • Armauer Hansen Research Institute (AHRI), Addis Ababa, Ethiopia.
  • Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, United States of America.
  • Departments of Epidemiology and Global Health, Emory Rollins School of Public Health, Atlanta, Georgia, United States of America.

ORCID-Profile: Shewki Moga, Betselot Zerihun, Getu Diriba

Förderung

  • FIC NIH HHS
  • NIAID NIH HHS
  • Fogarty International Center

Zitieren

APA

Moga, S., Bobosha, K., Fikadu, D., Zerihun, B., Diriba, G., Amare, M., Kempker, R. R., Blumberg, H. M., & Abebe, T. (2023). Diagnostic performance of the GenoType MTBDRplus VER 2.0 line probe assay for the detection of isoniazid resistant Mycobacterium tuberculosis in Ethiopia. PLOS ONE. https://doi.org/10.1371/journal.pone.0284737

Vancouver

Moga S, Bobosha K, Fikadu D, Zerihun B, Diriba G, Amare M, et al. Diagnostic performance of the GenoType MTBDRplus VER 2.0 line probe assay for the detection of isoniazid resistant Mycobacterium tuberculosis in Ethiopia. PLOS ONE. 2023. doi:10.1371/journal.pone.0284737

BibTeX
@article{Moga2023,
  author = {Moga, Shewki and Bobosha, Kidist and Fikadu, Dinka and Zerihun, Betselot and Diriba, Getu and Amare, Misikir and Kempker, Russell R and Blumberg, Henry M and Abebe, Tamrat},
  title = {Diagnostic performance of the GenoType MTBDRplus VER 2.0 line probe assay for the detection of isoniazid resistant Mycobacterium tuberculosis in Ethiopia},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0284737}
}
Kostenlos starten →